InfoNow Corporation – Trademark Portfolio
Entity Type: 03
InfoNow Corporation holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CHANNELINSIGHT. The owner is based in Denver, CO.
1875 Lawrence Street Suite 1100
Denver, CO 80202
Showing of trademarks Trademarks
Trademark Classifications
InfoNow Corporation's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does InfoNow Corporation have?
InfoNow Corporation has 13 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 8 cancelled.
What trademark classes does InfoNow Corporation file in?
InfoNow Corporation files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 39 (Transportation & Storage). Class 42 covers scientific and technological services; industrial analysis and research services.
What are InfoNow Corporation's most well-known trademarks?
InfoNow Corporation's registered trademark portfolio includes well-known marks such as CHANNELINSIGHT. These are among 1 currently registered trademark in the portfolio.
What is InfoNow Corporation's trademark registration success rate?
InfoNow Corporation has a 8% trademark registration rate, with 1 out of 13 resolved applications resulting in successful registration. Currently, 0 applications are pending review.